equityflowunderstand the flow and follow it
EquityFlow › Companies › Curve Therapeutics

Curve Therapeutics

biotech · Southampton, GB

Southampton biotech with an intracellular screening platform (Microcycle) for cancer drug discovery.

In the network

Shares the most investors with (number = shared investors):
Proximie 2

Funding history

DateRoundAmount
Feb 2024Series A
Curve Therapeutics closed a £40.5M Series A led by Pfizer Ventures to accelerate its cancer drug candidates toward human trials.
$51M

Investors

Tap an investor to see what else they have backed.

Advent Life SciencesBritish Patient CapitalColumbus Venture PartnersEpidarex CapitalPfizer Ventures

Other companies in biotech

Antag TherapeuticsAdcendoFreya BiosciencesTXN SystemsPromise BioConcinnity GeneticsNoema PharmaMabGenesisRadioNano TherapeuticsCitryllAlveron PharmaAQEMIA

Other companies in GB

Capsa AI01HealthRem3dy HealthNewOrbitJoyvié HealthFuse EnergyAirspeedSembleWordsmithOxford Quantum CircuitsFreshaImperagen

Other companies at Series A stage

&Done&Open011h01Health1000 Satellites100ms11x.ai12 Pharmacy180° Seguros1X Technologies1k Kirana Bazaar207
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.